

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cholesterol esterification (GO:0010872) | 6.59660949 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54548607 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.54548607 |
| 4 | regulation of protein activation cascade (GO:2000257) | 6.50637550 |
| 5 | negative regulation of fibrinolysis (GO:0051918) | 6.48371395 |
| 6 | regulation of fibrinolysis (GO:0051917) | 6.32697486 |
| 7 | high-density lipoprotein particle remodeling (GO:0034375) | 6.28500595 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.23015321 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 6.23015321 |
| 10 | regulation of complement activation (GO:0030449) | 6.13465245 |
| 11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.10745672 |
| 12 | protein carboxylation (GO:0018214) | 6.10745672 |
| 13 | plasma lipoprotein particle assembly (GO:0034377) | 5.94474085 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.93767951 |
| 15 | phospholipid efflux (GO:0033700) | 5.92190964 |
| 16 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.81943569 |
| 17 | protein-lipid complex remodeling (GO:0034368) | 5.75143187 |
| 18 | macromolecular complex remodeling (GO:0034367) | 5.75143187 |
| 19 | plasma lipoprotein particle remodeling (GO:0034369) | 5.75143187 |
| 20 | reverse cholesterol transport (GO:0043691) | 5.71255668 |
| 21 | negative regulation of cholesterol transport (GO:0032375) | 5.65761796 |
| 22 | negative regulation of sterol transport (GO:0032372) | 5.65761796 |
| 23 | cholesterol efflux (GO:0033344) | 5.63156141 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.55926768 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.48168767 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 5.26630319 |
| 27 | protein-lipid complex assembly (GO:0065005) | 5.20297985 |
| 28 | cellular glucuronidation (GO:0052695) | 5.07095092 |
| 29 | epoxygenase P450 pathway (GO:0019373) | 4.99188980 |
| 30 | drug catabolic process (GO:0042737) | 4.98987253 |
| 31 | uronic acid metabolic process (GO:0006063) | 4.96154362 |
| 32 | glucuronate metabolic process (GO:0019585) | 4.96154362 |
| 33 | blood coagulation, intrinsic pathway (GO:0007597) | 4.95504823 |
| 34 | fibrinolysis (GO:0042730) | 4.90333438 |
| 35 | plasma lipoprotein particle organization (GO:0071827) | 4.75594674 |
| 36 | low-density lipoprotein particle remodeling (GO:0034374) | 4.68993712 |
| 37 | exogenous drug catabolic process (GO:0042738) | 4.66642858 |
| 38 | regulation of plasminogen activation (GO:0010755) | 4.64877523 |
| 39 | negative regulation of lipase activity (GO:0060192) | 4.61157957 |
| 40 | aromatic amino acid family catabolic process (GO:0009074) | 4.53268183 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 4.52352240 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.52132768 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.52132768 |
| 44 | ethanol oxidation (GO:0006069) | 4.52073284 |
| 45 | negative regulation of protein activation cascade (GO:2000258) | 4.46038674 |
| 46 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.45684472 |
| 47 | protein-lipid complex subunit organization (GO:0071825) | 4.42339796 |
| 48 | bile acid biosynthetic process (GO:0006699) | 4.31055728 |
| 49 | urea metabolic process (GO:0019627) | 4.29247741 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.27769151 |
| 51 | bile acid metabolic process (GO:0008206) | 4.22866220 |
| 52 | daunorubicin metabolic process (GO:0044597) | 4.20415514 |
| 53 | polyketide metabolic process (GO:0030638) | 4.20415514 |
| 54 | doxorubicin metabolic process (GO:0044598) | 4.20415514 |
| 55 | omega-hydroxylase P450 pathway (GO:0097267) | 4.15432681 |
| 56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.10158655 |
| 57 | drug metabolic process (GO:0017144) | 4.04471662 |
| 58 | phospholipid homeostasis (GO:0055091) | 4.03354026 |
| 59 | negative regulation of blood coagulation (GO:0030195) | 4.01966343 |
| 60 | negative regulation of hemostasis (GO:1900047) | 4.01966343 |
| 61 | cholesterol homeostasis (GO:0042632) | 3.94035509 |
| 62 | regulation of bile acid biosynthetic process (GO:0070857) | 3.93245992 |
| 63 | sterol homeostasis (GO:0055092) | 3.87964011 |
| 64 | serine family amino acid catabolic process (GO:0009071) | 3.86942383 |
| 65 | negative regulation of coagulation (GO:0050819) | 3.84948605 |
| 66 | urea cycle (GO:0000050) | 3.84780355 |
| 67 | nitrogen cycle metabolic process (GO:0071941) | 3.82307524 |
| 68 | cholesterol transport (GO:0030301) | 3.79930060 |
| 69 | sterol transport (GO:0015918) | 3.79930060 |
| 70 | phenylpropanoid metabolic process (GO:0009698) | 3.79868747 |
| 71 | L-ascorbic acid metabolic process (GO:0019852) | 3.79037714 |
| 72 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.75923687 |
| 73 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74987839 |
| 74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74987839 |
| 75 | ethanol metabolic process (GO:0006067) | 3.74223207 |
| 76 | protein activation cascade (GO:0072376) | 3.72795405 |
| 77 | proline metabolic process (GO:0006560) | 3.70341069 |
| 78 | glycine metabolic process (GO:0006544) | 3.64132083 |
| 79 | lipoprotein metabolic process (GO:0042157) | 3.62839903 |
| 80 | intestinal absorption (GO:0050892) | 3.61757445 |
| 81 | negative regulation of wound healing (GO:0061045) | 3.60072594 |
| 82 | acute-phase response (GO:0006953) | 3.57200768 |
| 83 | negative regulation of complement activation (GO:0045916) | 3.54783822 |
| 84 | drug transmembrane transport (GO:0006855) | 3.53594122 |
| 85 | regulation of humoral immune response (GO:0002920) | 3.50344028 |
| 86 | regulation of apoptotic cell clearance (GO:2000425) | 3.48678770 |
| 87 | flavonoid metabolic process (GO:0009812) | 3.45283304 |
| 88 | bile acid and bile salt transport (GO:0015721) | 3.44750029 |
| 89 | complement activation, classical pathway (GO:0006958) | 3.37016931 |
| 90 | glutamate metabolic process (GO:0006536) | 3.35994274 |
| 91 | oxidative demethylation (GO:0070989) | 3.26358228 |
| 92 | tyrosine metabolic process (GO:0006570) | 3.26020027 |
| 93 | primary alcohol catabolic process (GO:0034310) | 3.25550195 |
| 94 | amino-acid betaine metabolic process (GO:0006577) | 3.24695748 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.19450465 |
| 96 | drug transport (GO:0015893) | 3.18868420 |
| 97 | positive regulation of hemostasis (GO:1900048) | 3.16958773 |
| 98 | positive regulation of blood coagulation (GO:0030194) | 3.16958773 |
| 99 | heme transport (GO:0015886) | 3.15569740 |
| 100 | complement activation (GO:0006956) | 3.14851417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.75305341 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.86824700 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.64880351 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.80618175 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.69232863 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.89163541 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.67387438 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.61582909 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.61425505 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51327009 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.16851136 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.98170148 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.81641264 |
| 14 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.60715537 |
| 15 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.23115417 |
| 16 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.06773334 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92484755 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80617974 |
| 19 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.79883989 |
| 20 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.64992065 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62567573 |
| 22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.48629497 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46070280 |
| 24 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.43623114 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.32076715 |
| 26 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.31404764 |
| 27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27407583 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26413031 |
| 29 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.23835302 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20556749 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18484157 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16146767 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16096620 |
| 34 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15848056 |
| 35 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14851357 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12799188 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12532265 |
| 38 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07766132 |
| 39 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07491325 |
| 40 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06739143 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06494311 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05967179 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04637467 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04423140 |
| 45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02913227 |
| 46 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02834204 |
| 47 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02069949 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99687662 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99384198 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98541482 |
| 51 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98500852 |
| 52 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95903892 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94325116 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93466625 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91613155 |
| 56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.89320539 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88938344 |
| 58 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88631992 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88631992 |
| 60 | CBP_21632823_ChIP-Seq_H3396_Human | 0.88586906 |
| 61 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.86818181 |
| 62 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85793571 |
| 63 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.85553784 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.82682010 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82679534 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.82207296 |
| 67 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81386189 |
| 68 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.80579030 |
| 69 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.79437621 |
| 70 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.79257178 |
| 71 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.79008209 |
| 72 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78297892 |
| 73 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77805055 |
| 74 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77720437 |
| 75 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.76326234 |
| 76 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75843020 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75039619 |
| 78 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.74119116 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73541228 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72905364 |
| 81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.72302366 |
| 82 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.72149271 |
| 83 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.69418148 |
| 84 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.69418148 |
| 85 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.69274076 |
| 86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.69177239 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 0.68853831 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.67933918 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66527705 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64738336 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64738336 |
| 92 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.63325150 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.63298382 |
| 94 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.63200311 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 0.62929545 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.62541247 |
| 97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.62298716 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.61596836 |
| 99 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.61397752 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 0.59945217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.04316448 |
| 2 | MP0005360_urolithiasis | 6.49331366 |
| 3 | MP0005365_abnormal_bile_salt | 5.79257974 |
| 4 | MP0003195_calcinosis | 5.21609248 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 5.18361113 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.13014244 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.82658264 |
| 8 | MP0009840_abnormal_foam_cell | 3.48842042 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.45796857 |
| 10 | MP0003252_abnormal_bile_duct | 3.45455031 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.42056564 |
| 12 | MP0003868_abnormal_feces_composition | 2.91392056 |
| 13 | MP0005332_abnormal_amino_acid | 2.35751236 |
| 14 | MP0002876_abnormal_thyroid_physiology | 1.98154081 |
| 15 | MP0009697_abnormal_copulation | 1.87785208 |
| 16 | MP0005408_hypopigmentation | 1.81584282 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 1.80619383 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.80451606 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.64861330 |
| 20 | MP0001764_abnormal_homeostasis | 1.58208700 |
| 21 | MP0002132_abnormal_respiratory_system | 1.57127010 |
| 22 | MP0000609_abnormal_liver_physiology | 1.55327185 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.54827691 |
| 24 | MP0003890_abnormal_embryonic-extraembry | 1.50199178 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.49637020 |
| 26 | MP0004272_abnormal_basement_membrane | 1.41434325 |
| 27 | MP0005670_abnormal_white_adipose | 1.36727253 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.36344231 |
| 29 | MP0003122_maternal_imprinting | 1.29345876 |
| 30 | MP0000566_synostosis | 1.20402339 |
| 31 | MP0002089_abnormal_postnatal_growth/wei | 1.15535203 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.11727419 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.05034277 |
| 34 | MP0003283_abnormal_digestive_organ | 1.04220983 |
| 35 | MP0006054_spinal_hemorrhage | 1.04132758 |
| 36 | MP0000598_abnormal_liver_morphology | 1.00842012 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.00423984 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 0.97455024 |
| 39 | MP0004264_abnormal_extraembryonic_tissu | 0.93158407 |
| 40 | MP0005083_abnormal_biliary_tract | 0.91694662 |
| 41 | MP0001915_intracranial_hemorrhage | 0.90972202 |
| 42 | MP0003186_abnormal_redox_activity | 0.89224542 |
| 43 | MP0001661_extended_life_span | 0.86907009 |
| 44 | MP0008872_abnormal_physiological_respon | 0.84901381 |
| 45 | MP0003123_paternal_imprinting | 0.82707187 |
| 46 | MP0005058_abnormal_lysosome_morphology | 0.82364201 |
| 47 | MP0004133_heterotaxia | 0.81916127 |
| 48 | MP0003718_maternal_effect | 0.81014682 |
| 49 | MP0001756_abnormal_urination | 0.80013736 |
| 50 | MP0002254_reproductive_system_inflammat | 0.77878116 |
| 51 | MP0009642_abnormal_blood_homeostasis | 0.77511836 |
| 52 | MP0000604_amyloidosis | 0.77389179 |
| 53 | MP0000639_abnormal_adrenal_gland | 0.76558177 |
| 54 | MP0005257_abnormal_intraocular_pressure | 0.76152181 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74138970 |
| 56 | MP0005395_other_phenotype | 0.70092477 |
| 57 | MP0005451_abnormal_body_composition | 0.68783559 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68469785 |
| 59 | MP0005187_abnormal_penis_morphology | 0.67491261 |
| 60 | MP0004043_abnormal_pH_regulation | 0.67033532 |
| 61 | MP0003943_abnormal_hepatobiliary_system | 0.66705245 |
| 62 | MP0010030_abnormal_orbit_morphology | 0.65462523 |
| 63 | MP0003119_abnormal_digestive_system | 0.64785387 |
| 64 | MP0010386_abnormal_urinary_bladder | 0.62621395 |
| 65 | MP0005376_homeostasis/metabolism_phenot | 0.58935265 |
| 66 | MP0002938_white_spotting | 0.58365779 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 0.58238187 |
| 68 | MP0002233_abnormal_nose_morphology | 0.56222367 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.56033419 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 0.55199149 |
| 71 | MP0003136_yellow_coat_color | 0.54196100 |
| 72 | MP0003315_abnormal_perineum_morphology | 0.53193962 |
| 73 | MP0002282_abnormal_trachea_morphology | 0.52268838 |
| 74 | MP0008004_abnormal_stomach_pH | 0.51192558 |
| 75 | MP0000516_abnormal_urinary_system | 0.50462297 |
| 76 | MP0005367_renal/urinary_system_phenotyp | 0.50462297 |
| 77 | MP0002090_abnormal_vision | 0.49716619 |
| 78 | MP0005448_abnormal_energy_balance | 0.49249953 |
| 79 | MP0003953_abnormal_hormone_level | 0.48620480 |
| 80 | MP0001324_abnormal_eye_pigmentation | 0.48528576 |
| 81 | MP0003638_abnormal_response/metabolism_ | 0.47419301 |
| 82 | MP0002909_abnormal_adrenal_gland | 0.47165254 |
| 83 | MP0003011_delayed_dark_adaptation | 0.44070310 |
| 84 | MP0000462_abnormal_digestive_system | 0.42847312 |
| 85 | MP0005023_abnormal_wound_healing | 0.40599017 |
| 86 | MP0005410_abnormal_fertilization | 0.40382132 |
| 87 | MP0001944_abnormal_pancreas_morphology | 0.40293516 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.39894065 |
| 89 | MP0002168_other_aberrant_phenotype | 0.39527692 |
| 90 | MP0001270_distended_abdomen | 0.38728573 |
| 91 | MP0002928_abnormal_bile_duct | 0.38600810 |
| 92 | MP0008469_abnormal_protein_level | 0.38138009 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.37891893 |
| 94 | MP0009384_cardiac_valve_regurgitation | 0.36802291 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.36266270 |
| 96 | MP0005164_abnormal_response_to | 0.35990622 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.35262078 |
| 98 | MP0003172_abnormal_lysosome_physiology | 0.35102764 |
| 99 | MP0005330_cardiomyopathy | 0.34313454 |
| 100 | MP0003879_abnormal_hair_cell | 0.33690370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 8.64679987 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 8.17704207 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 7.54740882 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.72317111 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.55464778 |
| 6 | Complement deficiency (HP:0004431) | 6.34444235 |
| 7 | Joint hemorrhage (HP:0005261) | 5.55681390 |
| 8 | Hypolipoproteinemia (HP:0010981) | 5.47418874 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 5.04299302 |
| 10 | Abnormality of complement system (HP:0005339) | 4.86257773 |
| 11 | Spontaneous abortion (HP:0005268) | 4.85601667 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.75427351 |
| 13 | Xanthomatosis (HP:0000991) | 4.73329342 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.44024040 |
| 15 | Glomerulonephritis (HP:0000099) | 4.34335909 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26210083 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 4.23169698 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.85767403 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.78807599 |
| 20 | Hyperglycinemia (HP:0002154) | 3.78029831 |
| 21 | Fat malabsorption (HP:0002630) | 3.74543316 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.56911269 |
| 23 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.42259537 |
| 24 | Hypercholesterolemia (HP:0003124) | 3.33812625 |
| 25 | Vascular calcification (HP:0004934) | 3.12121502 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.08886003 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.08886003 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 2.95636832 |
| 29 | Hyperglycinuria (HP:0003108) | 2.94023285 |
| 30 | Gingival bleeding (HP:0000225) | 2.84454370 |
| 31 | Delayed CNS myelination (HP:0002188) | 2.82268857 |
| 32 | Steatorrhea (HP:0002570) | 2.79937763 |
| 33 | Hemorrhage of the eye (HP:0011885) | 2.77286975 |
| 34 | Hyperammonemia (HP:0001987) | 2.75795518 |
| 35 | Glycosuria (HP:0003076) | 2.74599005 |
| 36 | Abnormality of urine glucose concentration (HP:0011016) | 2.74599005 |
| 37 | Epidermoid cyst (HP:0200040) | 2.73155361 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.72870219 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70487174 |
| 40 | Nephritis (HP:0000123) | 2.69279964 |
| 41 | Cardiovascular calcification (HP:0011915) | 2.67599989 |
| 42 | Mitral stenosis (HP:0001718) | 2.67094359 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.65533266 |
| 44 | Menorrhagia (HP:0000132) | 2.64998066 |
| 45 | Acanthocytosis (HP:0001927) | 2.63909975 |
| 46 | Hydroxyprolinuria (HP:0003080) | 2.62272867 |
| 47 | Abnormality of proline metabolism (HP:0010907) | 2.62272867 |
| 48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.58102716 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.51489306 |
| 50 | Enlarged kidneys (HP:0000105) | 2.49940284 |
| 51 | Increased serum pyruvate (HP:0003542) | 2.46234090 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.44111730 |
| 53 | Abnormal tarsal ossification (HP:0008369) | 2.43923265 |
| 54 | Arthropathy (HP:0003040) | 2.39926364 |
| 55 | Gout (HP:0001997) | 2.36334311 |
| 56 | Hypophosphatemic rickets (HP:0004912) | 2.35747569 |
| 57 | Rickets (HP:0002748) | 2.35497570 |
| 58 | Osteomalacia (HP:0002749) | 2.33037785 |
| 59 | Hypoglycemic coma (HP:0001325) | 2.27558312 |
| 60 | Facial shape deformation (HP:0011334) | 2.20413556 |
| 61 | Potter facies (HP:0002009) | 2.20413556 |
| 62 | Abnormality of carpal bone ossification (HP:0006257) | 2.19695352 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.18694311 |
| 64 | Retinal atrophy (HP:0001105) | 2.18643817 |
| 65 | Abnormality of glycolysis (HP:0004366) | 2.18181766 |
| 66 | Amyloidosis (HP:0011034) | 2.18005283 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.13918171 |
| 68 | Abnormality of vitamin metabolism (HP:0100508) | 2.12444350 |
| 69 | Thrombophlebitis (HP:0004418) | 2.12054494 |
| 70 | Hyperphosphaturia (HP:0003109) | 2.08194873 |
| 71 | Late onset (HP:0003584) | 2.03925886 |
| 72 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03513190 |
| 73 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.03014768 |
| 74 | Abnormal delivery (HP:0001787) | 1.99595965 |
| 75 | Bifid scrotum (HP:0000048) | 1.94965421 |
| 76 | Metabolic acidosis (HP:0001942) | 1.92114627 |
| 77 | Myocardial infarction (HP:0001658) | 1.86256990 |
| 78 | Hepatoblastoma (HP:0002884) | 1.86137029 |
| 79 | Hyperbilirubinemia (HP:0002904) | 1.82813485 |
| 80 | Pigmentary retinal degeneration (HP:0001146) | 1.81736387 |
| 81 | Vaginal fistula (HP:0004320) | 1.80009441 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78024989 |
| 83 | Joint swelling (HP:0001386) | 1.76769654 |
| 84 | Purpura (HP:0000979) | 1.70823892 |
| 85 | Broad alveolar ridges (HP:0000187) | 1.69626503 |
| 86 | Nausea (HP:0002018) | 1.69260219 |
| 87 | Lethargy (HP:0001254) | 1.68261913 |
| 88 | Abnormal urine phosphate concentration (HP:0012599) | 1.66466426 |
| 89 | Abnormality of alanine metabolism (HP:0010916) | 1.65481466 |
| 90 | Hyperalaninemia (HP:0003348) | 1.65481466 |
| 91 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65481466 |
| 92 | Poikilocytosis (HP:0004447) | 1.63860574 |
| 93 | Cerebral palsy (HP:0100021) | 1.63454303 |
| 94 | Hypothermia (HP:0002045) | 1.62168807 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 1.62060249 |
| 96 | Neoplasm of the liver (HP:0002896) | 1.60880637 |
| 97 | Abnormality of the vitreous humor (HP:0004327) | 1.58495507 |
| 98 | Prenatal maternal abnormality (HP:0002686) | 1.57666488 |
| 99 | Skin nodule (HP:0200036) | 1.55754959 |
| 100 | Ketosis (HP:0001946) | 1.53443207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 5.10850192 |
| 2 | PDK2 | 4.93717448 |
| 3 | ERBB4 | 3.79122359 |
| 4 | FGFR4 | 3.70645659 |
| 5 | ACVR1B | 3.30468255 |
| 6 | PBK | 2.89153390 |
| 7 | EPHA2 | 2.68989409 |
| 8 | MST1R | 2.12860475 |
| 9 | ERN1 | 2.10958353 |
| 10 | BCKDK | 2.07034751 |
| 11 | PIK3CA | 2.06583146 |
| 12 | WNK4 | 1.99130761 |
| 13 | MAP3K12 | 1.93796877 |
| 14 | FGFR3 | 1.82780828 |
| 15 | BMPR1B | 1.79426674 |
| 16 | FGFR2 | 1.77885745 |
| 17 | EPHA4 | 1.70646003 |
| 18 | STK39 | 1.66141727 |
| 19 | WNK3 | 1.64472605 |
| 20 | FGFR1 | 1.56383930 |
| 21 | GRK1 | 1.42934509 |
| 22 | EIF2AK3 | 1.39393395 |
| 23 | AKT3 | 1.37104961 |
| 24 | MET | 1.35087801 |
| 25 | NEK1 | 1.32676756 |
| 26 | BRSK2 | 1.30787696 |
| 27 | FRK | 1.27494630 |
| 28 | PRKG2 | 1.20759295 |
| 29 | MAPK11 | 1.16791508 |
| 30 | STK16 | 1.14527125 |
| 31 | PRKAA2 | 1.09724710 |
| 32 | ERBB2 | 1.08409337 |
| 33 | PIK3CG | 1.06704738 |
| 34 | VRK2 | 1.02180186 |
| 35 | RIPK1 | 1.01474300 |
| 36 | MST4 | 1.00492723 |
| 37 | TESK2 | 1.00128811 |
| 38 | FLT3 | 0.96636786 |
| 39 | BCR | 0.96033603 |
| 40 | TNIK | 0.94012701 |
| 41 | NEK2 | 0.91949231 |
| 42 | MAP4K2 | 0.89665142 |
| 43 | MYLK | 0.88063270 |
| 44 | LATS1 | 0.87343656 |
| 45 | STK38L | 0.87323526 |
| 46 | OXSR1 | 0.87149260 |
| 47 | CASK | 0.86639366 |
| 48 | INSRR | 0.86167956 |
| 49 | NME1 | 0.84404341 |
| 50 | MUSK | 0.84029401 |
| 51 | EIF2AK1 | 0.83971782 |
| 52 | FER | 0.83850629 |
| 53 | PRKCE | 0.79676170 |
| 54 | LIMK1 | 0.79168426 |
| 55 | TESK1 | 0.76310182 |
| 56 | PKN2 | 0.75790959 |
| 57 | ICK | 0.74591492 |
| 58 | MAPKAPK3 | 0.74192087 |
| 59 | PRKCG | 0.73613275 |
| 60 | PRKACG | 0.70219234 |
| 61 | TGFBR2 | 0.68629217 |
| 62 | PHKG1 | 0.66955806 |
| 63 | PHKG2 | 0.66955806 |
| 64 | DAPK1 | 0.61723270 |
| 65 | WEE1 | 0.60432608 |
| 66 | PDGFRA | 0.58902480 |
| 67 | BRSK1 | 0.55912514 |
| 68 | NUAK1 | 0.55465908 |
| 69 | PRKAA1 | 0.54060315 |
| 70 | TRIM28 | 0.51724804 |
| 71 | IGF1R | 0.49695842 |
| 72 | ABL2 | 0.48893460 |
| 73 | PDPK1 | 0.48402368 |
| 74 | CSNK1G1 | 0.47442199 |
| 75 | TAF1 | 0.47097597 |
| 76 | NTRK3 | 0.44197488 |
| 77 | MELK | 0.43355032 |
| 78 | CSNK2A1 | 0.43130559 |
| 79 | CSNK1A1 | 0.43124019 |
| 80 | CDK7 | 0.42746349 |
| 81 | PRKG1 | 0.42070593 |
| 82 | CSNK1E | 0.41847568 |
| 83 | CSNK2A2 | 0.41773638 |
| 84 | PINK1 | 0.41402373 |
| 85 | MAP3K2 | 0.40939932 |
| 86 | PLK3 | 0.40377741 |
| 87 | CDK9 | 0.39924288 |
| 88 | ZAK | 0.39656335 |
| 89 | CSNK1A1L | 0.37620657 |
| 90 | PRKACB | 0.37401678 |
| 91 | TIE1 | 0.36729632 |
| 92 | PAK4 | 0.35560720 |
| 93 | KDR | 0.35109811 |
| 94 | PRKCQ | 0.34993555 |
| 95 | CDK8 | 0.34227260 |
| 96 | ROCK1 | 0.33966869 |
| 97 | CSNK1D | 0.33745294 |
| 98 | PRKCA | 0.32477829 |
| 99 | PRKACA | 0.28890906 |
| 100 | PTK2 | 0.26295309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.65484040 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40215265 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.39678435 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.86492678 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84232649 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.83020407 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.59248932 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58667066 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.53317586 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.44688608 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.44128791 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.32148008 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28604778 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.27742452 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.12227811 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.07716337 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05326571 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.02497880 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.95227241 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88098462 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84622662 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.79979550 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.77938098 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.71319135 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69494820 |
| 26 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.68141179 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.66958642 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.66879804 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64395539 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60304698 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.57803539 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.53947872 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.51303671 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50032846 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.48727629 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46701136 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.39800041 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.31718916 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25650046 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25605995 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24717354 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23927141 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23368580 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18134435 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18105252 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.17799235 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15355826 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14904465 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10554037 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09661838 |
| 51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08029243 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07817358 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93776384 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84979365 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83235365 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81890702 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80706096 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.77959987 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76018897 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72308529 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71428584 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70156710 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69516617 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69145856 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64909873 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63267064 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62766938 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59715894 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59658501 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55872783 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52038122 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51952943 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.49381296 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.48615937 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48609047 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35512957 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.34676492 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33776963 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33379298 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32988288 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.30119994 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26673888 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25095156 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22247271 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20003581 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17194062 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.15533026 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.14088669 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12636383 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07566456 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.06567821 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.02962045 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.02454061 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.02154421 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.00981894 |
| 96 | Lysosome_Homo sapiens_hsa04142 | -0.0757800 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0700131 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0684889 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0551730 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0330614 |

